Regeneron Pharmaceuticals (REGN) Treasury Shares (2010 - 2026)

Regeneron Pharmaceuticals' Treasury Shares history runs 13 years deep, the most recent figure standing at $19.4 billion for Q1 2026.

• In Q1 2026, Treasury Shares rose 19.7% year-over-year to $19.4 billion; the TTM figure through Mar 2026 stood at $19.4 billion (up 19.7% YoY), while the FY2025 annual figure was $18.6 billion, up 22.72% from the prior year.
• Treasury Shares was $19.4 billion for Q1 2026 at Regeneron Pharmaceuticals, up from $18.6 billion in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $34.7 million in Q1 2026 to a low of $900000.0 in Q1 2023.
• Historically, Treasury Shares has averaged $21.2 million across 5 years, with a median of $25.5 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Treasury Shares jumped 33.79% in 2022, then grew 14.36% in 2024.
• A 5-year view of Treasury Shares shows it stood at $10.4 billion in 2022, then rose by 21.32% to $12.6 billion in 2023, then climbed by 20.76% to $15.2 billion in 2024, then advanced by 22.72% to $18.6 billion in 2025, then grew by 4.3% to $19.4 billion in 2026.
• The last three Treasury Shares figures came in at $19.4 billion (Q1 2026), $18.6 billion (Q4 2025), and $17.9 billion (Q3 2025), per Business Quant data.